Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Validation of a French version of Roland-Morris questionnaire in chronic low back pain patients.

Zerkak D, Métivier JC, Fouquet B, Beaudreuil J.

Ann Phys Rehabil Med. 2013 Dec;56(9-10):613-20. doi: 10.1016/j.rehab.2013.08.006. Epub 2013 Sep 24.

2.

Care related pain and functional restoration for chronic low back pain: a prospective study.

Beaudreuil J, Zerkak D, Métivier JC, Fouquet B.

Ann Phys Rehabil Med. 2013 Sep;56(6):455-64. doi: 10.1016/j.rehab.2013.06.004. Epub 2013 Jul 15.

3.

Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability.

Beaudreuil J, Allard A, Zerkak D, Gerber RA, Cappelleri JC, Quintero N, Lasbleiz S, Bernabé B, Orcel P, Bardin T; URAM Study Group.

Arthritis Care Res (Hoboken). 2011 Oct;63(10):1448-55. doi: 10.1002/acr.20564.

4.

[Skin necrosis with oral anticoagulant].

Rouaghe S, Zerkak D, Barclay F, Aras N.

Rev Prat. 2011 Mar;61(3):312. French. No abstract available.

PMID:
21563401
5.

Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases.

Gilson M, Zerkak D, Wipff J, Dusser D, Dinh-Xuan AT, Abitbol V, Chaussade S, Legmann P, Kahan A, Allanore Y.

Eur Respir J. 2010 Jan;35(1):112-7. doi: 10.1183/09031936.00060209. Epub 2009 Jun 18.

6.

Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.

Wipff J, Avouac J, Borderie D, Zerkak D, Lemarechal H, Kahan A, Boileau C, Allanore Y.

Rheumatology (Oxford). 2008 Jul;47(7):972-5. doi: 10.1093/rheumatology/ken100. Epub 2008 May 13.

PMID:
18477643
7.

High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.

Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.

8.

Influence of patient education on exercise compliance in rheumatoid arthritis: a prospective 12-month randomized controlled trial.

Mayoux-Benhamou A, Giraudet-Le Quintrec JS, Ravaud P, Champion K, Dernis E, Zerkak D, Roy C, Kahan A, Revel M, Dougados M.

J Rheumatol. 2008 Feb;35(2):216-23. Epub 2007 Dec 15.

PMID:
18085742
9.

Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial.

Giraudet-Le Quintrec JS, Mayoux-Benhamou A, Ravaud P, Champion K, Dernis E, Zerkak D, Ouslimani A, Courpied JP, Revel M, Kahan A, Dougados M.

J Rheumatol. 2007 Aug;34(8):1684-91. Epub 2007 Jun 15.

PMID:
17610321
10.

[Knee septic arthritis].

Jenny JY, Lortat-Jacob A, Boisrenoult P, Zerkak D, Pujol N, Ziza JM, Gaudias J.

Rev Chir Orthop Reparatrice Appar Mot. 2006 Dec;92(8 Suppl):4S46-54. French.

PMID:
17245253
11.

[Haematological complications of prostatic cancer: 2 cases, one revealing the neoplasia].

Albiges L, Cottu PH, Cojean-Zelek I, Raymond F, Zerkak D, Aerts J, Ziza JM.

Rev Med Interne. 2007 Mar;28(3):176-8. Epub 2007 Jan 3. French.

PMID:
17229492
12.

Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.

Soubrier M, Zerkak D, Dougados M.

J Rheumatol. 2006 Sep;33(9):1766-9.

PMID:
16845709
13.

Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?

Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M.

J Rheumatol. 2006 Jul;33(7):1243-6. Epub 2006 Apr 15.

PMID:
16622906
14.

How to define a Minimal Clinically Individual State (MCIS) with pain VAS in daily practice for patients suffering from musculoskeletal disorders.

Falgarone G, Zerkak D, Bauer C, Messow M, Dougados M.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):235-8.

PMID:
15895896
15.

Benefit/risk of combination therapies.

Zerkak D, Dougados M.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S71-6. Review.

PMID:
15552518
16.

The use of glucosamine therapy in osteoarthritis.

Zerkak D, Dougados M.

Curr Pain Headache Rep. 2004 Dec;8(6):507-11. Review.

PMID:
15509466
17.

The use of glucosamine therapy in osteoarthritis.

Zerkak D, Dougados M.

Curr Rheumatol Rep. 2004 Feb;6(1):41-5. Review.

PMID:
14713401
18.

[Bone evaluation in ten adults with cutaneous mastocytosis].

Armingaud P, Zerkak D, Lespessailles E, Petavy-Catala C, Kerdraon R, Benhamou CL, Estève E.

Ann Dermatol Venereol. 2002 Feb;129(2):170-2. French.

19.

[Clinical elements of the diagnostic guidelines for low back pain].

Goupille P, Avimadje AM, Zerkak D, Valat JP.

Rev Prat. 2000 Oct 15;50(16):1760-4. French.

PMID:
11103125
20.

Destructive hip disease complicating traumatic paraplegia.

Avimadje AM, Pellieux S, Goupille P, Zerkak D, Valat JP, Fouquet B.

Joint Bone Spine. 2000;67(4):334-6.

PMID:
10963084
21.

Monostotic fibrous dysplasia of the lumbar spine.

Avimadje AM, Goupille P, Zerkak D, Begnard G, Brunais-Besse J, Valat JP.

Joint Bone Spine. 2000 Jan;67(1):65-70. Review.

PMID:
10773971
22.

Cervical spine involvement in psoriatic arthritis.

Jeannou J, Goupille P, Avimadje MA, Zerkak D, Valat JP, Fouquet B.

Rev Rhum Engl Ed. 1999 Dec;66(12):695-700.

PMID:
10649603
23.

[Poisoning with "poppers", a rare cause of methemoglobinemia observed in emergency cases].

Staïkowsky F, Perret A, Péviriéri F, Zanker C, Zerkak D, Pelloux P, Danhiez F.

Presse Med. 1997 Oct 4;26(29):1381-4. French.

PMID:
9404346

Supplemental Content

Loading ...
Support Center